July 12, 2017

Three generations rally to raise funds for lung disease research

Local Brisbane architect, Elisa Knowlman, has rallied three generations of her family to raise much needed funding for research into chronic lung disease, which affects 1 in 4 Australians[i] including her mum who is fighting a chronic progressive lung disease.

Elisa, her 84-year old father (Greg) and her niece (Isobel) will join over 100 riders in Lung Foundation Australia’s unique 4 hour cycle challenge on July 14 at Lakeside Park Raceway in a bid to raise $100,000 for lung disease research. They are calling on the Brisbane community to show support by making a donation at www.lungfoundation.com.au/cycledonate

Elisa has watched as her mother Doris deteriorate in health since she was diagnosed with Chronic Obstructive Pulmonary Disease (COPD) five years ago.

“Lung disease doesn’t discriminate, it can affect anyone. More funding into research will give people with lung disease hope, improve their quality of life and one day find a cure,” Elisa said.

COPD is a debilitating and progressive lung disease which causes shortness of breath and has resulted in Doris now relying on home oxygen.

“We’re determined to do what we can to raise awareness and funds for this often forgotten and neglected disease area and I urge the community to show their support by making an online donation,” Elisa said.

Lung Foundation Australia CEO Ms Heather Allan said lung disease, including thoracic cancers and chronic respiratory diseases, is the second leading cause of death in Australia[ii], yet publicity, empathy, research and funding remain extremely low.

“We need to make lung disease a priority and to do this we need the backing from the community to help raise the profile of this neglected disease,” she said.

“We’re hoping to raise $100,000 to support research that will improve outcomes and the quality of life for people with a lung disease, and thanks to the support of Novartis, we are able to commit 100% of the funds raised to support this vital research,” she said.

Novartis’ Business Franchise Director, Respiratory, Kate Norton, said they were pleased to be supporting this unique initiative.

“Novartis is committed to enhancing health outcomes for patients and health-care providers so we are delighted to be supporting Lung Foundation Australia to raise money for lung disease research,” Ms Norton said.

“We have signed up a team and encourage everyone in Brisbane to get involved and support this worthy and important cause.”

The community can show their support by donating online to the Corporate Cycle Challenge at www.lungfoundation.com.au/cycledonate.


[i] AIHW, 2016, http://www.aihw.gov.au/chronic-respiratory-conditions/

[ii] ABS, Australia’s Leading Causes of Death, 2015, www.abs.gov.au